articleThe LancetFeb 1, 2008Closed access

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

DJDavid J. KuterJBJames B. BusselRMRoger M. LyonsVPVinod PullarkatTGTerry Gernsheimer

Massachusetts General Hospital · NewYork–Presbyterian Hospital · +30 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

861
total citations
FWCI
37.80
Percentile
100%
References
45
Citations per year

Authors

32

Topics & keywords

Topics
Keywords
  • Romiplostim
  • Medicine
  • Thrombocytopenic purpura
  • Placebo
  • Platelet
  • Clinical endpoint
  • Thrombopoiesis
  • Thrombopoietin
No related works found for this paper.